S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
Log in

Urogen Pharma SEC Filings & 10K Form (NASDAQ:URGN)

$22.15
-0.02 (-0.09 %)
(As of 10/16/2019 04:00 PM ET)
Today's Range
$21.95
Now: $22.15
$22.49
50-Day Range
$20.92
MA: $29.11
$36.47
52-Week Range
$20.72
Now: $22.15
$55.49
Volume94,600 shs
Average Volume209,691 shs
Market Capitalization$462.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.14

SEC Filings

Urogen Pharma (NASDAQ:URGN) SEC Filings

DateFilerForm TypeView
10/04/2019
3:16 PM
Urogen Pharma (Subject)
Wildcat Capital Management, LLC (Filed by)
Form SC 13G
09/24/2019
4:20 PM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
8:27 AM
Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
12:31 PM
PFREUNDSCHUH PETER P. (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
2:38 PM
Mullennix Stephen (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
7:32 AM
Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
7:16 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
4:11 PM
Urogen Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/07/2019
4:00 PM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
5:21 PM
Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
4:02 PM
Tomasello Shawn (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:59 PM
FALBERG KATHRYN E (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:58 PM
BUTITTA CYNTHIA M (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:57 PM
Cohen Fred E (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:55 PM
Nussbaum Ran (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:54 PM
Holden Stuart (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:52 PM
Belldegrun Arie (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
8:40 AM
Arkin Moshe (Filed by)
Urogen Pharma (Subject)
Form SC 13D/A
05/28/2019
4:00 PM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2019
5:20 PM
Mullennix Stephen (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
7:12 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
6:13 AM
Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2019
4:00 PM
Urogen Pharma (Filer)
Form DEF 14A
03/28/2019
3:52 PM
Belldegrun Arie (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:42 PM
Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:41 PM
Cohen Fred E (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
8:46 PM
Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
8:44 PM
Mullennix Stephen (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
8:43 PM
Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 3/A
02/28/2019
12:08 PM
Urogen Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
7:16 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
8:37 AM
MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
02/14/2019
6:51 AM
Consonance Capital Management LP (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
02/13/2019
11:06 AM
FMR LLC (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
02/12/2019
8:34 AM
Urogen Pharma (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
01/29/2019
4:26 PM
Mullennix Stephen (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:25 PM
PFREUNDSCHUH PETER P. (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
4:24 PM
Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
7:01 AM
Urogen Pharma (Filer)
Form 424B5
01/25/2019
6:30 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2019
4:12 PM
Urogen Pharma (Filer)
Form 424B5
01/22/2019
4:08 PM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2019
5:58 PM
Holden Stuart (Reporting)
Urogen Pharma (Issuer)
Form 3/A
01/15/2019
5:56 PM
Cohen Fred E (Reporting)
Urogen Pharma (Issuer)
Form 3/A
01/11/2019
3:00 PM
ProQuest Investments IV, L.P. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
01/10/2019
4:19 PM
Tomasello Shawn (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:18 PM
Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:17 PM
PFREUNDSCHUH PETER P. (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:16 PM
Nussbaum Ran (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:15 PM
Mullennix Stephen (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:13 PM
Holden Stuart (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:12 PM
FALBERG KATHRYN E (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:11 PM
Cohen Fred E (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:10 PM
BUTITTA CYNTHIA M (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:09 PM
BENTSUR RON (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2019
4:08 PM
Belldegrun Arie (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2019
7:25 PM
Barrett Elizabeth A. (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
4:38 PM
Barrett Elizabeth A. (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2019
11:48 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
5:33 AM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2018
2:36 PM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2018
11:16 PM
Urogen Pharma (Filer)
Form EFFECT
10/12/2018
4:27 PM
Urogen Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/12/2018
4:24 PM
Urogen Pharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
09/21/2018
7:05 AM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2018
7:01 AM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2018
3:24 PM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2018
12:46 PM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/12/2018
7:07 PM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2018
1:03 PM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2018
1:01 PM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2018
10:09 AM
Arkin Moshe (Filed by)
Urogen Pharma (Subject)
Form SC 13D
05/15/2018
3:24 PM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2018
3:04 PM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2018
3:48 PM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/15/2018
4:10 PM
Urogen Pharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/20/2018
8:11 AM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2018
12:43 PM
Pontifax Management III G.P. Ltd. (0001726335) (Filed by)
Urogen Pharma (Subject)
Form SC 13D
02/14/2018
9:55 AM
Consonance Capital Management LP (Filed by)
Urogen Pharma (Subject)
Form SC 13G
02/14/2018
9:48 AM
MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
02/09/2018
2:18 PM
Urogen Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/22/2018
3:07 PM
Urogen Pharma (Filer)
Form 424B4
01/18/2018
11:15 PM
Urogen Pharma (Filer)
Form EFFECT
01/18/2018
5:01 PM
Urogen Pharma (Filer)
Form F-1MEF
01/16/2018
3:04 PM
Urogen Pharma (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
01/11/2018
3:27 PM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2018
5:09 AM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/14/2017
5:02 AM
Urogen Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2017
9:00 AM
MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: Blockchain

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel